Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Which Is Better Target Date Funds Or Age Based Strategy: Brief. A quick look at the trade-offs between these approaches to help you decide what suits you.
27,345 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
SpaceX remains privately held, but chatter about a public listing fuels the myth that a superstar IPO will power the ...
Traders online are buzzing about turns $100k $1.28m year as a 3x semiconductor play surged over the last 12 months. T...
Broadcom is slated to report fiscal Q2 results after the market closes today, with investors focusing on AI-driven re...
Public rifts among celebrity families can complicate daily life and future planning. This piece examines how Pax Joli...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....
Stocks ended mixed as the Dow stayed relatively calm while Nasdaq slipped. Earnings, rates, and sector rotation shape...
If you’re wondering whether Eli Lilly stock still has room to run, you’re not alone. This guide outlines scenarios fo...
Bitcoin selling pressure weakens as a surge in U.S. spot ETF inflows shows renewed demand. This article breaks down w...
BlackRock launches BITA, a Bitcoin Premium Income ETF that channels crypto volatility into monthly distributions via ...
A rigorous, on-the-ground look at whether a $40,000 annual budget can buy a stress-free retirement on Spain’s Costa d...
Fresh data from Stanford and ADP shows AI exposure weighing on entry-level hiring, challenging hopes that automation ...